NCT07915609: A Study to Learn About Berobenatide Given Once Weekly in Adults With Knee Osteoarthritis and Overweight or Obesity With or Without Type 2 Diabetes (VESPER-OA 2)
- State
- Under way
- Phase
- Phase 3
- People
- 756 planned
- Started
- 26 Oct 2026
- Primary completion
- 21 Aug 2028
- Arms
- Arm 1: Berobenatide Once Weekly, Arm 2: Berobenatide Once Weekly, Arm 3: Berobenatide Once Weekly
- Results
- None posted
- 26 Oct 2026: Trial started
- 4 Nov 2026: Trial registered